Palantir’s Rich Valuation Faces a Key Earnings Test
A packed earnings week pits high-multiple growth stocks like Palantir and AMD against cheaper names such as Toyota, HSBC, and MUFG. Palantir’s 129.54 P/E makes its Aug. 3 report a standout test, while banks, industrials, and healthcare names offer a valuation reality check.
This week’s earnings lineup pits premium growth names against cheaper value stocks, with Palantir’s 129.54 P/E drawing the sharpest scrutiny. Investors will be watching whether recent beats and strong analyst support can justify elevated multiples, while banks and automakers offer lower-valuation alternatives with steadier expectations.
The week of Aug. 3, 2026, puts premium growth, global banking, industrial machinery, pharmaceuticals, and autos on the same earnings stage. High valuations at AMD (AMD), Palantir Technologies (PLTR), and Arista Networks (ANET) face a direct test against cheaper names such as Toyota Motor (TM), HSBC Holdings (HSBC), and Mitsubishi UFJ Financial Group (MUFG).
Key Takeaways
Palantir Technologies (PLTR) reports Aug. 3 after the market closes, with a 129.54 P/E and a recent EPS result of $0.33 versus a $0.2774 estimate.
AMD reports Aug. 4 after the close. Its $476.15 price sits below the 50-day average of $512.21, while analysts still record a Buy consensus.
Healthcare brings two large tests: Merck (MRK) on Aug. 4 and Eli Lilly (LLY) on Aug. 5. Both carry Buy consensus ratings, but Lilly trades at a much richer 39.04 P/E.
Caterpillar (CAT), Toyota (TM), and the major banks offer a valuation counterweight, with P/E ratios of 40, 9.65, and 16.04, respectively.
Mitsubishi UFJ Financial Group (MUFG): Banking Value Meets Earnings Momentum
Mitsubishi UFJ Financial Group (MUFG) reports on Aug. 3. The Tokyo-based financial group serves retail, commercial, corporate, investment banking, asset management, and global markets clients across Japan and international markets. Its latest quote shows a price of $22.45, down 0.22% on the session.
However, the broader price structure remains firm. MUFG trades above its 50-day average of $20.73 and its 200-day average of $17.94, while its 52-week range reaches $23.25 at the top. The stock carries a 16.04 P/E. Two analysts rate it Buy, and the consensus is Buy.
The latest recorded earnings comparison adds support to the setup. On May 21, MUFG posted EPS of $0.38 against an estimate of $0.20. That result gives the market a clear recent earnings beat to measure against. The combination of a relatively modest multiple, a Buy consensus, and a price above both moving averages creates a value-oriented benchmark for the week.
Palantir Technologies (PLTR): A Premium AI Software Test
Palantir Technologies (PLTR) reports Aug. 3 after the market closes. The software company sells Gotham, Foundry, Apollo, and its Palantir Artificial Intelligence Platform, or AIP, to government and commercial customers. The stock recently closed at $123.06, up 0.65%, with volume of 27.95 million shares versus an average of 41.33 million.
Still, the price remains below both the 50-day average of $130.72 and the 200-day average of $152.89. PLTR sits inside a wide $106.37 to $207.52 52-week range and carries a 129.54 P/E. That multiple sets a demanding bar for any earnings update.
The latest earnings comparison was favorable. On May 4, Palantir reported EPS of $0.33 against an estimate of $0.2774. Analysts record 12 Buy ratings, 11 Holds, and 3 Sells, producing a Buy consensus. Therefore, the market enters the report with strong analyst support but a stock price that still trades below its longer-term average. Execution must justify more than a good headline number at this valuation.
Toyota Motor (TM): Low Valuation, Global Auto Exposure
Toyota Motor (TM) reports on Aug. 4. The Japanese automaker sells passenger vehicles, commercial vehicles, hybrids, fuel-cell vehicles, trucks, and related financial services across global markets. Its American depositary shares recently traded at $188.99, down 1.28%.
The quote sits above the 50-day average of $178.92 but below the 200-day average of $203.62. Toyota's 52-week range runs from $166.10 to $248.90. At 9.65, its P/E is the lowest among the focus stocks covered here.
Toyota's latest recorded EPS result also exceeded its estimate. On May 8, the company reported $4.00 against an estimate of $3.11. Analysts list 6 Buys and 10 Holds, with a Hold consensus. The market therefore has a cheaper stock, a recent earnings beat, and a more cautious rating profile. That mix makes the report an important test of whether value can hold its ground beside high-growth names.
Caterpillar (CAT): Industrial Strength Against a High Bar
Caterpillar (CAT) reports on Aug. 4. The industrial company manufactures construction and mining equipment, power units, industrial turbines, and related financial products. Its shares recently reached $814.81, up 0.70% on the session.
Despite that daily gain, CAT remains below its 50-day average of $920.08. It trades above the 200-day average of $738.12, while the 52-week range extends to $1,073.46. The stock carries a 40 P/E, placing it well above Toyota and HSBC on earnings valuation.
The most recent earnings comparison was strong. On April 30, Caterpillar posted EPS of $5.54 versus an estimate of $4.65. Analysts record 31 Buys, 21 Holds, and 4 Sells, resulting in a Buy consensus. That recent beat supports the bullish rating, but the 40 P/E leaves less room for an ordinary result to excite the stock.
HSBC Holdings (HSBC): A Cheaper Bank With a Cautious Rating
HSBC Holdings (HSBC) reports on Aug. 4. The London-based bank operates across wealth and personal banking, commercial banking, and global banking and markets. Its American depositary shares recently traded at $106.42, down 0.63%, close to the 52-week high of $107.59.
The price remains above its 50-day average of $96.45 and its 200-day average of $84.93. HSBC carries a 13.64 P/E, below CAT, MRK, LLY, AMD, PLTR, and ANET among the focus names. That valuation gives the bank a clear value profile.
The latest earnings comparison was less supportive than MUFG's. On May 5, HSBC reported EPS of $2.00 against an estimate of $2.18. Analysts list 8 Buys, 11 Holds, and 2 Sells, producing a Hold consensus. As a result, HSBC enters the earnings calendar with strong price positioning but a recent EPS miss and a more reserved analyst view.
Merck (MRK): Healthcare Stability With a Recent EPS Improvement
Merck (MRK) reports on Aug. 4. The healthcare company operates in pharmaceuticals and animal health, with products spanning oncology, vaccines, immunology, hospital care, and veterinary medicine. The stock recently traded at $130.22, up 0.33%.
MRK sits above its 50-day average of $122.54 and its 200-day average of $111.37. Its 52-week range reaches $135.05, and the stock carries a 23.81 P/E. Analysts list 25 Buys, 11 Holds, and 1 Sell, supporting a Buy consensus.
On April 30, Merck reported EPS of negative $1.28 against an estimate of negative $1.47. The reported result was higher than the estimate because the loss was smaller. Therefore, the upcoming report has a recent earnings comparison that favors the company, while the price and analyst data show a more stable setup than the high-growth software names.
Space Exploration Technologies (SPCX): Growth Ambition Meets Profitability Pressure
Space Exploration Technologies (SPCX) reports on Aug. 4. The aerospace and defense company designs and launches rockets, manufactures spacecraft, and provides satellite broadband through Starlink. Its latest quote shows a price of $108.37, down 3.41%.
The stock sits just above its 52-week low of $107.01 and well below its high of $225.64. It also trades below the 50-day and 200-day averages, both listed at $145.41. Current EPS stands at negative $1.10, while the P/E is negative 98.52.
Analysts record 3 Buys, with no Holds or Sells, producing a Buy consensus. That rating profile gives the growth story clear support, but the negative EPS shifts attention toward the company's ability to convert aerospace, satellite, and launch activity into profits. The market enters with an optimistic analyst view and a stock sitting near its annual low, a combination that can produce sharp reactions to earnings.
AMD (AMD): Semiconductor Growth Still Carries a Premium
Advanced Micro Devices (AMD) reports on Aug. 4 after the market closes. AMD develops processors, graphics chips, data center products, embedded solutions, and semi-custom systems. The shares recently traded at $476.15, down 1.90%, with volume of 25.32 million shares against an average of 33.03 million.
AMD trades below its 50-day average of $512.21 but remains well above its 200-day average of $311.82. The stock's 52-week range runs from $149.22 to $584.73. At 103.96, its P/E ranks among the highest in the group.
The latest EPS comparison was positive. On May 5, AMD posted $1.37 against an estimate of $1.29. Analysts list 50 Buys and 20 Holds, creating a Buy consensus with no Sell ratings. That combination of a recent beat and broad analyst support supports the growth case. Still, the valuation means the market has already assigned substantial value to future semiconductor expansion.
Arista Networks (ANET): Networking Momentum at a Rich Multiple
Arista Networks (ANET) reports on Aug. 4 after the market closes. The company supplies cloud networking hardware, operating systems, routing products, and network applications to internet companies, telecom providers, financial institutions, governments, and media businesses.
ANET recently traded at $180.35, up 5.46% in one session. The price sits above its 50-day average of $166.58 and its 200-day average of $145.85, near the 52-week high of $189.82. The stock carries a 56.89 P/E.
On May 5, Arista reported EPS of $0.87 against an estimate of $0.808. Analysts list 39 Buys and 13 Holds, with no Sell ratings, producing a Buy consensus. The recent price surge, earnings beat, and analyst support create a strong growth profile. Yet the valuation remains high enough that a routine result would face a demanding market response.
Eli Lilly (LLY): Pharmaceutical Leadership With a High Valuation
Eli Lilly (LLY) reports on Aug. 5. The pharmaceutical company sells medicines across diabetes, oncology, autoimmune disease, neurology, pain management, and other therapeutic areas. Its shares recently traded at $1,148.50, down 0.56%.
The price sits slightly above the 50-day average of $1,144.77 and above the 200-day average of $1,023.15. Lilly's 52-week range extends from $623.78 to $1,249.45. Its P/E is 39.04, while analysts list 33 Buys, 9 Holds, and 3 Sells.
The latest earnings comparison was notably strong. On April 30, Lilly reported EPS of $8.55 against an estimate of $6.97. The Buy consensus reinforces the growth view, while the 39.04 P/E places the stock close to CAT's valuation and above MRK's. Consequently, Lilly's report adds a major healthcare test to a week already crowded with high-expectation names.
Other Earnings to Watch
Gilead Sciences (GILD), Healthcare, Drug Manufacturers - General, reports Aug. 3, 2026.
ConocoPhillips (COP), Energy, Oil & Gas E&P, reports Aug. 6, 2026.
Parker-Hannifin (PH), Industrials, Specialty Industrial Machinery, reports Aug. 6, 2026.
Cloudflare (NET), Technology, Software - Infrastructure, reports Aug. 5, 2026.
This earnings week brings a useful split between expensive growth and established value. AMD, PLTR, ANET, and LLY carry strong analyst support, while MUFG, HSBC, and Toyota offer lower P/E ratios. The next round of results will show which side of that valuation divide can turn recent earnings strength into durable market leadership.
▌Common Questions
Frequently asked questions
+When does Palantir report earnings this week?
Palantir Technologies reports on Aug. 3 after the market closes. The stock enters the release with a very high valuation and a recent earnings beat already in hand.
+Why is Palantir’s earnings report important for investors?
Palantir is trading at a rich 129.54 P/E, so the market needs more than a modest beat to support the stock. Investors will be looking for strong execution and guidance that can justify the premium valuation.
+Which cheaper stocks are also reporting in this earnings week?
Mitsubishi UFJ Financial Group, Toyota Motor, HSBC Holdings, and Caterpillar are among the lower-valuation names on the schedule. These stocks give investors a value-oriented comparison to high-multiple growth names like Palantir and AMD.
+What do Toyota and MUFG show about the market setup this week?
Toyota and MUFG both come into earnings with relatively modest P/E ratios and recent EPS beats. That makes them useful benchmarks for whether investors are favoring value and earnings consistency over premium growth valuations.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
